Aldeyra Therapeutics (ALDX)
(Delayed Data from NSDQ)
$5.89 USD
-0.15 (-2.48%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $5.76 -0.13 (-2.21%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ALDX 5.89 -0.15(-2.48%)
Will ALDX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ALDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALDX
Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?
ALDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why
Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
Here's Why You Should Invest in Aldeyra (ALDX) Stock Now
Other News for ALDX
Biotech Alert: Searches spiking for these stocks today
Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Aldeyra Therapeutics Announces Executive Team Changes
Undercovered Dozen: United Natural Foods, Procter & Gamble, Archer Aviation, Embraer +
Aldeyra Therapeutics Has Data To Trigger AbbVie Partnership